NIHR Invention for Innovation (i4i) Product Development Award
Vesynta is a funded industrial co-investigator in the ‘ChromaDose’ project alongside a 20-member consortium. Vesynta will support ChromaDose’s vision for all children receiving anthracycline chemotherapies to benefit from personalised treatment, by expertly developing hardware solutions that enable bedside drug monitoring of children with cancer.
For more information, please visit: www.chromadose.org
Innovate UK: Innovation Scholars Secondments
Vesynta hosts two talented individuals; Dr Shelby Barnett (Newcastle University) and Dr Anand Pallipurath (University College London), as secondees.
Anand’s skills in microfluidic engineering and advanced computational image analysis are leveraged to support Vesynta’s efforts to monitor cancer therapy levels. Shelby's experience of managing a national drug monitoring facility is essential to her enhancement of user experience, interface and analytical performance of Vesynta's platform.